Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-541468 Japanese versus Caucasian healthy volunteer PK/PD study
NL-OMON45722Phase 1Active, not recruiting
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia and sleep disorder comparing ACT-541468 with Placebo (2 arms). Primary endpoints: Safety and tolerability, Cmax and 6 more. Started Mar 2017; status: active, not recruiting.
02
Drugs
daridorexant
03
Conditions
Insomniasleep disorder
Beyond the preview
Go deeper on NL-OMON45722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45722.